Arcutis Biotherapeutics Statistics
Total Valuation
ARQT has a market cap or net worth of $3.29 billion. The enterprise value is $3.17 billion.
| Market Cap | 3.29B |
| Enterprise Value | 3.17B |
Important Dates
The last earnings date was Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ARQT has 125.69 million shares outstanding. The number of shares has increased by 5.07% in one year.
| Current Share Class | 125.69M |
| Shares Outstanding | 125.69M |
| Shares Change (YoY) | +5.07% |
| Shares Change (QoQ) | +5.05% |
| Owned by Insiders (%) | 1.78% |
| Owned by Institutions (%) | 83.97% |
| Float | 92.98M |
Valuation Ratios
The trailing PE ratio is 121.58 and the forward PE ratio is 37.59.
| PE Ratio | 121.58 |
| Forward PE | 37.59 |
| PS Ratio | 7.09 |
| Forward PS | 5.46 |
| PB Ratio | 14.91 |
| P/TBV Ratio | 15.91 |
| P/FCF Ratio | 84.08 |
| P/OCF Ratio | 83.74 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 86.77, with an EV/FCF ratio of 80.90.
| EV / Earnings | 111.06 |
| EV / Sales | 6.83 |
| EV / EBITDA | 86.77 |
| EV / EBIT | 92.47 |
| EV / FCF | 80.90 |
Financial Position
The company has a current ratio of 2.92, with a Debt / Equity ratio of 0.52.
| Current Ratio | 2.92 |
| Quick Ratio | 2.46 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | 3.06 |
| Debt / FCF | 2.92 |
| Interest Coverage | 2.47 |
Financial Efficiency
Return on equity (ROE) is 15.86% and return on invested capital (ROIC) is 37.79%.
| Return on Equity (ROE) | 15.86% |
| Return on Assets (ROA) | 5.09% |
| Return on Invested Capital (ROIC) | 37.79% |
| Return on Capital Employed (ROCE) | 10.44% |
| Weighted Average Cost of Capital (WACC) | 12.61% |
| Revenue Per Employee | $1.31M |
| Profits Per Employee | $80,562 |
| Employee Count | 354 |
| Asset Turnover | 1.10 |
| Inventory Turnover | 1.49 |
Taxes
In the past 12 months, ARQT has paid $779,000 in taxes.
| Income Tax | 779,000 |
| Effective Tax Rate | 2.66% |
Stock Price Statistics
The stock price has increased by +67.56% in the last 52 weeks. The beta is 1.53, so ARQT's price volatility has been higher than the market average.
| Beta (5Y) | 1.53 |
| 52-Week Price Change | +67.56% |
| 50-Day Moving Average | 26.35 |
| 200-Day Moving Average | 25.59 |
| Relative Strength Index (RSI) | 47.42 |
| Average Volume (20 Days) | 1,481,828 |
Short Selling Information
The latest short interest is 12.69 million, so 10.09% of the outstanding shares have been sold short.
| Short Interest | 12.69M |
| Short Previous Month | 13.56M |
| Short % of Shares Out | 10.09% |
| Short % of Float | 13.64% |
| Short Ratio (days to cover) | 9.61 |
Income Statement
In the last 12 months, ARQT had revenue of $463.98 million and earned $28.52 million in profits. Earnings per share was $0.22.
| Revenue | 463.98M |
| Gross Profit | 422.89M |
| Operating Income | 34.25M |
| Pretax Income | 29.30M |
| Net Income | 28.52M |
| EBITDA | 36.50M |
| EBIT | 34.25M |
| Earnings Per Share (EPS) | $0.22 |
Balance Sheet
The company has $238.55 million in cash and $114.14 million in debt, with a net cash position of $124.42 million or $0.99 per share.
| Cash & Cash Equivalents | 238.55M |
| Total Debt | 114.14M |
| Net Cash | 124.42M |
| Net Cash Per Share | $0.99 |
| Equity (Book Value) | 220.58M |
| Book Value Per Share | 1.76 |
| Working Capital | 307.33M |
Cash Flow
In the last 12 months, operating cash flow was $39.31 million and capital expenditures -$158,000, giving a free cash flow of $39.15 million.
| Operating Cash Flow | 39.31M |
| Capital Expenditures | -158,000 |
| Depreciation & Amortization | 2.25M |
| Net Borrowing | n/a |
| Free Cash Flow | 39.15M |
| FCF Per Share | $0.31 |
Margins
Gross margin is 91.14%, with operating and profit margins of 7.38% and 6.15%.
| Gross Margin | 91.14% |
| Operating Margin | 7.38% |
| Pretax Margin | 6.31% |
| Profit Margin | 6.15% |
| EBITDA Margin | 7.87% |
| EBIT Margin | 7.38% |
| FCF Margin | 8.44% |
Dividends & Yields
ARQT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.07% |
| Shareholder Yield | -5.07% |
| Earnings Yield | 0.87% |
| FCF Yield | 1.19% |
Analyst Forecast
The average price target for ARQT is $36.88, which is 40.82% higher than the current price. The consensus rating is "Buy".
| Price Target | $36.88 |
| Price Target Difference | 40.82% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 30.15% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ARQT has an Altman Z-Score of 4.86 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.86 |
| Piotroski F-Score | 7 |